ストックスクリーナーアプリを入手
28.87
8.84%
2.29
前日終値:
$26.58
開ける：
$28.45
24時間の取引高:
3.81M
Relative Volume:
1.15
時価総額：
$2.32B
収益：
-
当期純損益:
$-96.66M
株価収益率:
-13.43
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
+6.17%
1か月 パフォーマンス:
+232.53%
6か月 パフォーマンス:
+587.17%
1年 パフォーマンス:
+200.10%
1日の値動き範囲:
$27.75
$30.24
1週間の範囲:
$25.62
$30.24
52週間の値動き範囲:
$2.86
$30.24
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
OLMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
28.99 | 2.13B | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.10 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
708.12 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
893.67 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
409.75 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
195.05 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-08 | 開始されました | Guggenheim | Buy |
| 2025-08-12 | 繰り返されました | Citigroup | Buy |
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2024-01-30 | 開始されました | Citigroup | Buy |
| 2023-07-21 | 開始されました | Oppenheimer | Outperform |
| 2023-05-05 | 開始されました | CapitalOne | Overweight |
| 2023-02-22 | 開始されました | Credit Suisse | Outperform |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | Canaccord Genuity | Buy |
| 2020-12-14 | 開始されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | JP Morgan | Overweight |
| 2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
Olema Oncology (OLMA) Shares Surge Over 11% - GuruFocus
Olema Pharmaceuticals stock hits 52-week high at $29.57 By Investing.com - Investing.com Canada
Roche's SERD Trial Boosts Olema Pharmaceuticals (OLMA) Stock - GuruFocus
Diadema Partners LP Increases Stock Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals joins SABCS25 to advance breast cancer therapies - Traders Union
Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 7.7%Here's Why - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Moves Forward with Clinical Trials - Kalkine Media
XTX Topco Ltd Makes New Investment in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals, Inc. $OLMA Shares Bought by Schroder Investment Management Group - MarketBeat
Affinity Asset Advisors LLC Lowers Holdings in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Olema Pharmaceuticals (OLMA) price target increased by 53.92% to 37.23 - MSN
Olema Pharmaceuticals Inc Stock Analysis and ForecastVolume Profile Analysis & Turn Data into Profits With Our Strategies - earlytimes.in
Why Olema Pharmaceuticals Inc. stock is rated strong buyChart Signals & Capital Protection Trade Alerts - Newser
Why retail investors favor Olema Pharmaceuticals Inc. stockMarket Sentiment Review & Long-Term Growth Plans - Newser
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals seeks senior medical director to advance oncology care - Traders Union
Olema Pharmaceuticals (OLMA) Stock Analysis Report | Financials & Insights - Benzinga
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance - MSN
Olema Pharmaceuticals (OLMA): Assessing Valuation Following $190 Million Equity Offering and Underwriter Changes - Sahm
Olema Pharmaceuticals (NASDAQ:OLMA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Will Olema Pharmaceuticals Inc. stock pay special dividends2025 Price Targets & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ
Olema Pharmaceuticals stock hits 52-week high at 27.25 USD By Investing.com - Investing.com Canada
Olema Pharmaceuticals stock hits 52-week high at 27.25 USD - Investing.com
15,000 Shares in Olema Pharmaceuticals, Inc. $OLMA Bought by Titleist Asset Management LLC - MarketBeat
Olema Pharmaceuticals (OLMA) Bolsters Balance Sheet but Will Fresh Capital Accelerate Oncology Innovation? - Sahm
Olema Pharmaceuticals : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Dir Rappaport Acquires 35,868 Of Olema Pharmaceuticals Inc [OLMA] - TradingView
[Form 4] Olema Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Olema Pharmaceuticals Reports Increased Losses Amid R&D Expansion - MSN
Olema Pharmaceuticals (OLMA): Evaluating the Current Valuation After a Strong Run-Up in Recent Months - Yahoo Finance
Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA) - MSN
LifeSci Capital Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA) - The Globe and Mail
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
The Goldman Sachs Group Boosts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $26.00 - MarketBeat
Olema Oncology to Participate in Upcoming Investor Conferences - Sahm
Research Analysts Set Expectations for OLMA Q1 Earnings - MarketBeat
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference - The Manila Times
Goldman Sachs Maintains Olema Pharmaceuticals (OLMA) Buy Recommendation - MSN
Olema Pharmaceuticals Inc. (OLMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Small Cap Stocks To Keep An Eye OnNovember 18th - MarketBeat
Goldman Sachs Raises Price Target for Olema Pharmaceuticals (OLM - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 26%What's Next? - MarketBeat
Commit To Purchase Olema Pharmaceuticals At $16, Earn 40.4% Annualized Using Options - Nasdaq
Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Olema Pharmaceuticals Closes $218.5 Million Public Offering of Common Stock - Quiver Quantitative
Olema Oncology (Nasdaq: OLMA) Completes $218.5M Equity Sale at $19 Per Share - Stock Titan
Olema Pharmaceuticals (NASDAQ:OLMA) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Olema Pharmaceuticals Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock - MarketScreener
What technical signals suggest for Olema Pharmaceuticals Inc. stockStop Loss & Momentum Based Trading Signals - newser.com
Why Olema Pharmaceuticals Inc. stock is in analyst buy zoneProfit Target & AI Based Trade Execution Alerts - newser.com
Will Olema Pharmaceuticals Inc. continue its uptrendIPO Watch & Short-Term Swing Trade Alerts - newser.com
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
0.04%
0.80%
大文字化:
|
ボリューム (24 時間):